Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
Clinical trial NCT01227967 · COMPLETED
Trial details
- NCT number
- NCT01227967
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2016-05-02
- Enrollment
- 881
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.